Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis

Running, not enrolling · Phase 3

Conditions studied: Generalized Myasthenia Gravis

In brief

The RAISE-XT study is an open-label extension study to evaluate the long-term efficacy, safety, and tolerability of zilucoplan in subjects with gMG who have previously participated in a qualifying Ra Pharmaceuticals sponsored zilucoplan study.

Key facts

Study ID

NCT04225871

Run by

UCB Biopharma SRL

People needed

200

Starts

2019-12-23

Expected to finish

2026-07-27

Last updated by the study team

2026-07-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Completion of a qualifying zilucoplan study

You may not qualify if…

• With the exception of a prior zilucoplan trial, participation in another concurrent clinical trial involving an experimental therapeutic intervention (participation in observational studies and/or registry studies is permitted)

Where it is running

• Mg0011 116 — Phoenix, Arizona, United States
• Mg0011 31 — Irvine, California, United States
• MG0011 4 — Los Angeles, California, United States
• Mg0011 220 — Pasadena, California, United States
• Mg0011 160 — San Francisco, California, United States
• Mg0011 24 — New Haven, Connecticut, United States
• Mg0011 27 — Washington D.C., District of Columbia, United States
• Mg0011 25 — Tampa, Florida, United States
• Mg0011 135 — Augusta, Georgia, United States
• Mg0011 188 — Glenview, Illinois, United States
• Mg0011 156 — Indianapolis, Indiana, United States
• Mg0011 32 — Kansas City, Kansas, United States
• Mg0011 33 — Detroit, Michigan, United States
• Mg0011 49 — East Lansing, Michigan, United States
• Mg0011 134 — Columbia, Missouri, United States
• Mg0011 117 — Las Vegas, Nevada, United States
• Mg0011 30 — Buffalo, New York, United States
• Mg0011 123 — Great Neck, New York, United States
• Mg0011 23 — New York, New York, United States
• Mg0011 47 — New York, New York, United States
• Mg0011 22 — Chapel Hill, North Carolina, United States
• Mg0011 122 — Cleveland, Ohio, United States
• Mg0011 38 — Columbus, Ohio, United States
• Mg0011 40 — Pittsburgh, Pennsylvania, United States
• Mg0011 41 — Mobile, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.